Refitting the Model for End-Stage Liver Disease for the Eurotransplant Region.

Ben F J Goudsmit Hein Putter Maarten E Tushuizen Serge Vogelaar Jacques Pirenne Ian P J Alwayn Bart van Hoek Andries E Braat

Published in: Hepatology (Baltimore, Md.) (2021)

Refitting MELD resulted in new lower and upper bounds for each parameter. The predictive power of reMELD-Na was significantly higher than UNOS-MELD. ReMELD prioritized patients with higher 90-day mortality rates. Thus, reMELD(-Na) should replace UNOS-MELD for liver graft allocation in the Eurotransplant region.

Keyphrases

cardiovascular events
risk factors